HC Wainwright Has Optimistic Outlook of MLYS Q1 Earnings
Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Free Report) – Research analysts at HC Wainwright boosted their Q1 2025 earnings per share (EPS) estimates for Mineralys Therapeutics in a report issued on Wednesday, April 2nd. HC Wainwright analyst M. Caufield now anticipates that the company will post earnings per share of ($0.90) for the quarter, up from […]
